Drugmakers are raising list prices on at least 350 medications in 2026. Medicare Part D caps out-of-pocket drug spending at $2,100 this year. So do the hikes still matter for seniors? Yes, but the impact is less about the annual total and more about what ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into effect until 2028.

Since September, 16 major drug companies have inked deals with the Trump administration to lower prices. But in January — the time of year when pharmaceutical companies typically roll out price hikes — all 16 companies released higher list prices for ...

Negotiated prices for Kisqali and Verzenio, which the agency said cost Medicare over $1 billion in a year, would become effective starting 2028.